» Articles » PMID: 26497555

ZNF32 Protects Against Oxidative Stress-induced Apoptosis by Modulating C1QBP Transcription

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Oct 27
PMID 26497555
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS)-driven oxidative stress has been recognized as a critical inducer of cancer cell death in response to therapeutic agents. Our previous studies have demonstrated that zinc finger protein (ZNF)32 is key to cell survival upon oxidant stimulation. However, the mechanisms by which ZNF32 mediates cell death remain unclear. Here, we show that at moderate levels of ROS, Sp1 directly binds to two GC boxes within the ZNF32 promoter to activate ZNF32 transcription. Alternatively, at cytotoxic ROS concentrations, ZNF32 expression is repressed due to decreased binding activity of Sp1. ZNF32 overexpression maintains mitochondrial membrane potential and enhances the antioxidant capacity of cells to detoxify ROS, and these effects promote cell survival upon pro-oxidant agent treatment. Alternatively, ZNF32-deficient cells are more sensitive and vulnerable to oxidative stress-induced cell injury. Mechanistically, we demonstrate that complement 1q-binding protein (C1QBP) is a direct target gene of ZNF32 that inactivates the p38 MAPK pathway, thereby exerting the protective effects of ZNF32 on oxidative stress-induced apoptosis. Taken together, our findings indicate a novel mechanism by which the Sp1-ZNF32-C1QBP axis protects against oxidative stress and implicate a promising strategy that ZNF32 inhibition combined with pro-oxidant anticancer agents for hepatocellular carcinoma treatment.

Citing Articles

ZNF32 histidine 179 and 183 single-site and double-site mutations promote nuclear speckle formation but differentially regulate the proliferation of breast cancer cells.

Zhong C, Chen D, Wang F, Wang J, Li R, Li Y Front Cell Dev Biol. 2025; 13:1490231.

PMID: 40046230 PMC: 11880268. DOI: 10.3389/fcell.2025.1490231.


A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response.

Li M, Su C, Wang Q, Chen Y, Jiang D, Wang W Discov Oncol. 2025; 16(1):94.

PMID: 39870934 PMC: 11772917. DOI: 10.1007/s12672-025-01803-0.


Zinc finger proteins facilitate adaptation of a global insect pest to climate change.

Li T, Guo J, Hu G, Cao F, Su H, Shen M BMC Biol. 2024; 22(1):303.

PMID: 39741276 PMC: 11689702. DOI: 10.1186/s12915-024-02109-3.


Transcriptomic response of overexpression ZNF32 in breast cancer cells.

Zhong C, Chen D, Gong D, Sheng X, Lin Y, Li R Sci Rep. 2024; 14(1):28407.

PMID: 39557972 PMC: 11574142. DOI: 10.1038/s41598-024-80125-7.


ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, mA modification, and drug susceptibility.

Ding Y, Gong Y, Zeng H, Song G, Yu Z, Fu B Aging (Albany NY). 2023; 15(13):6179-6211.

PMID: 37400985 PMC: 10373972. DOI: 10.18632/aging.204827.


References
1.
Jin M, Ande A, Kumar A, Kumar S . Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway. Cell Death Dis. 2013; 4:e554. PMC: 3615729. DOI: 10.1038/cddis.2013.78. View

2.
Gorrini C, Harris I, Mak T . Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013; 12(12):931-47. DOI: 10.1038/nrd4002. View

3.
Li K, Wei Y, Zhang J, Li J, Gao B, Huang L . Cytoplasmic expression, antibody production, and characterization of the novel zinc finger protein 637. Appl Microbiol Biotechnol. 2012; 97(2):741-9. DOI: 10.1007/s00253-012-4235-5. View

4.
Mi Y, Hou B, Liao Q, Ma Y, Luo Q, Dai Y . Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity. Cell Death Differ. 2012; 19(7):1175-86. PMC: 3374081. DOI: 10.1038/cdd.2011.206. View

5.
Kasahara A, Scorrano L . Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol. 2014; 24(12):761-70. DOI: 10.1016/j.tcb.2014.08.005. View